4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-004573
Chief Executive Officer sold 700 shares at $21.38 ($14,966)
- Chief Executive Officer acquired 1,360 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2026-01-02 | Option exercise | +1,360 | 5,382 | D | ||
| Schambye Hans T. Chief Executive Officer | 2026-01-02 | Sale | −700 | $21.38 | $14,966 | 4,682 | D |
| Derivatives | |||||||
| Schambye Hans T. Chief Executive Officer | 2026-01-02 | Option exercise · Restricted Stock Units | −1,360 | 2,640 | D | ||
| Open-market sales · 700 sh · avg $21.38 · $14,966 | |||||||
Loading xslF345X05/ownership.xml…